- Home
- OSUR vs CADL Comparison
OSUR vs CADL Comparison
Compare OSUR & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- CADL
- Stock Information
- Founded
- OSUR 2000
- CADL 1999
- Country
- OSUR United States
- CADL United States
- Employees
- OSUR N/A
- CADL N/A
- Industry
- OSUR Medical/Dental Instruments
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- CADL Health Care
- Exchange
- OSUR Nasdaq
- CADL Nasdaq
- Market Cap
- OSUR 223.0M
- CADL 244.2M
- IPO Year
- OSUR 1986
- CADL 2021
- Fundamental
- Price
- OSUR $2.99
- CADL $4.98
- Analyst Decision
- OSUR Hold
- CADL Strong Buy
- Analyst Count
- OSUR 2
- CADL 4
- Target Price
- OSUR $5.50
- CADL $21.00
- AVG Volume (30 Days)
- OSUR 624.9K
- CADL 1.0M
- Earning Date
- OSUR 05-07-2025
- CADL 05-13-2025
- Dividend Yield
- OSUR N/A
- CADL N/A
- EPS Growth
- OSUR N/A
- CADL N/A
- EPS
- OSUR N/A
- CADL N/A
- Revenue
- OSUR $185,827,000.00
- CADL N/A
- Revenue This Year
- OSUR N/A
- CADL N/A
- Revenue Next Year
- OSUR $7.55
- CADL N/A
- P/E Ratio
- OSUR N/A
- CADL N/A
- Revenue Growth
- OSUR N/A
- CADL N/A
- 52 Week Low
- OSUR $2.69
- CADL $3.79
- 52 Week High
- OSUR $5.59
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- OSUR 43.10
- CADL 40.01
- Support Level
- OSUR $2.84
- CADL $4.41
- Resistance Level
- OSUR $3.10
- CADL $5.25
- Average True Range (ATR)
- OSUR 0.15
- CADL 0.42
- MACD
- OSUR 0.02
- CADL 0.12
- Stochastic Oscillator
- OSUR 37.50
- CADL 67.59
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.